|
ATP2C1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.043200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.397800E-02 |
| Normal-vs-Stage2 |
6.346800E-01 |
| Normal-vs-Stage3 |
1.737000E-01 |
| Normal-vs-Stage4 |
7.248400E-01 |
| Stage1-vs-Stage2 |
6.850200E-01 |
| Stage1-vs-Stage3 |
7.758600E-01 |
| Stage1-vs-Stage4 |
9.754600E-01 |
| Stage2-vs-Stage3 |
5.530400E-01 |
| Stage2-vs-Stage4 |
8.574000E-01 |
| Stage3-vs-Stage4 |
9.501000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.787000E-01 |
| Normal-vs-AfricanAmerican |
3.492800E-01 |
| Normal-vs-Asian |
6.691800E-01 |
| Caucasian-vs-AfricanAmerican |
9.211000E-01 |
| Caucasian-vs-Asian |
9.339000E-01 |
| AfricanAmerican-vs-Asian |
9.551400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.017700E-02 |
| Normal-vs-Female |
1.203400E-01 |
| Male-vs-Female |
3.161700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.202400E-01 |
| Normal-vs-Extreme_Weight |
5.284900E-03 |
| Normal-vs-Obese |
3.748600E-01 |
| Normal-vs-Extreme_Obese |
6.593800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.745400E-01 |
| Normal_Weight-vs-Obese |
7.513000E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.154600E-01 |
| Extreme_Weight-vs-Obese |
1.621960E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.095400E-01 |
| Obese-vs-Extreme_Obese |
9.418800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.187400E-01 |
| Normal-vs-Age(41-60Yrs) |
9.833800E-01 |
| Normal-vs-Age(61-80Yrs) |
4.731700E-02 |
| Normal-vs-Age(81-100Yrs) |
8.513800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.138800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.387800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.512100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.046790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.020440E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.696200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.893800E-01 |
| Normal-VS-Type2 PRCC |
1.904780E-03 |
| Normal-VS-KIRP CIMP |
1.436820E-01 |
| Normal-VS-Unclassified PRCC |
4.925400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.600500E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.114050E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.797800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.839500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.449900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.408750E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.022000E-03 |
| Normal-vs-N1 |
9.309400E-01 |
| Normal-vs-N2 |
7.523000E-01 |
| N0-vs-N1 |
7.477600E-02 |
| N0-vs-N2 |
5.779800E-01 |
| N1-vs-N2 |
7.642200E-01 |
|
|
